[Anti-tumor Effect of Infection on Melanoma in Mice]
Overview
Authors
Affiliations
Objective: To explore the anti-tumor effect of 17XL strains of (P.y) infection on melanoma in mice.
Methods: B16F10 tumor cells were axillarilly injected into the right flank of 20 C57BL/6 mice to establish tumor-bearing mouse models. The next day, the mice were randomly divided into a P.y infection group and control group, 10 mice each group. Each mouse of the P.y infection group was intraperitoneally injected with 1×10 red blood cells including 20% P.y infection red blood cells, and each one of the control group were intraperitoneally injected with 1×10 normal red blood cells of C57BL/6 mice. The time of tumor formation of the mice in the two groups was observed and the tumor volumes were measured.
Results: The time of tumor formation in the P.y infection group[ (11.30 ± 0.21) d]was significantly later than that in the control group [ (10.40 ± 0.22) d] ( < 0.05). From the tumors could be accurately measured to the study end point, both the tumors of mice in the two groups were growing, and the tumor volumes of mice in the P.y infection group were significantly less than those in the control group at each time point (all < 0.05). The growth rate of tumors in the P.y infection group [ (71.10 ± 6.29) mm/d] was significantly slower than that in the control group [ (302.80 ± 49.94) mm/d] ( < 0.05), and the growth rates of tumors everyday in the P.y infection group were significantly slower than those in the control group (all < 0.05).
Conclusions: The P.y infection can delay the occurrence of tumor and inhibit the growth of melanoma.
Maravelez Acosta V, Garcia M, Patino Lopez G, Crisostomo Vazquez M, Franco Sandoval L, Eligio Garcia L Int J Mol Sci. 2025; 25(24.
PMID: 39769340 PMC: 11678856. DOI: 10.3390/ijms252413577.
Parasites revive hope for cancer therapy.
Eissa M, Salem A, El Skhawy N Eur J Med Res. 2024; 29(1):489.
PMID: 39367471 PMC: 11453045. DOI: 10.1186/s40001-024-02057-2.
Yao X, Cao Y, Lu L, Xu Y, Chen H, Liu C Parasit Vectors. 2022; 15(1):192.
PMID: 35668501 PMC: 9169289. DOI: 10.1186/s13071-022-05291-x.